Aalto Helsinki
Aalto-Helsinki is a student-driven synthetic biology research team from Aalto University and University of Helsinki, participating in the iGEM competition since 2014 as Finland's first entrant. The team develops annual proof-of-concept biotech projects addressing healthcare, environmental, and sustainability challenges through genetic engineering and molecular biology, with no commercial revenue.
- Company typePrivate
- Founded2014
- HeadquartersHelsinki, Finland
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Aalto Helsinki does
Aalto-Helsinki is a student-driven synthetic biology competition team jointly operated by students from Aalto University (Espoo) and the University of Helsinki (Helsinki, Finland), founded in 2014 as the first Finnish team to participate in the international iGEM (International Genetically Engineered Machine) competition. The team fields a multidisciplinary roster of approximately 9-14 students per annual cycle spanning biology, biotechnology, bioinformatics, mathematics, chemistry, programming, design, and engineering, and operates sub-teams covering wet-lab, dry-lab, fundraising, collaboration, programming, writing, human practices, graphic design, social media, and video.
The team's core technology stack is synthetic biology and genetic engineering using standardized BioBrick parts, with project-specific applications including protein engineering, ribosome display, DARPin design, quorum-sensing biosensors, antimicrobial peptide production in E. coli, and computational modeling. Notable historical and ongoing projects include: a 2014 remote-controlled bacterial gene expression system; 2015 propane production; 2016 cyanotoxin detection and degradation via engineered yeast; 2017 dermcidin-derived (DCD-1L) antimicrobial peptides for acne in E. coli; 2018 microbial natural dyes combined with spider silk proteins; the 2022 QBlock project using DARPins to bind AIP molecules and prevent biofilm formation in chronic wounds (which won a Gold Medal at the Grand Jamboree in Paris); 2023 PET upcycling into single-cell proteins; and the 2026 fusion protein-based histamine test-strip biosensor for home-use detection by histamine-intolerant individuals. The team operates under academic mentorship with laboratory access at Aalto University, the University of Helsinki, HiLife (Helsinki Institute of Life Science), and VTT Technical Research Centre of Finland.
Aalto-Helsinki does not operate a commercial business. There are no products or services sold, no pricing model, and no commercial revenue stream. The entity is funded through university institutional support, in-kind laboratory sponsorship (notably from Thermo Fisher Scientific, IDT, BioNordika, Geneious), and financial sponsorship (Kemianteollisuus, TEK, ERASynBio, Loimu). All projects are academic proof-of-concept research, not commercial products; the Gold Medal at the 2022 Grand Jamboree represents the team's primary measurable competitive credential. Outreach activities include a podcast on Spotify, blog, Instagram, LinkedIn, science workshops at Heureka, and public presentations at Science Basement.
Aalto Helsinki firmographics
Firmographics- Name
- Aalto Helsinki
- Legal name
- Aalto-Helsinki
- Website
- https://aaltohelsinki.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Aalto-Helsinki is a student-driven synthetic biology research team from Aalto University and University of Helsinki, participating in the iGEM competition since 2014 as Finland's first entrant. The team develops annual proof-of-concept biotech projects addressing healthcare, environmental, and sustainability challenges through genetic engineering and molecular biology, with no commercial revenue.
- Ownership category
- akta.pro rank
Aalto Helsinki industry classification
Industry- Product category
- Synthetic Biology Research
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- “Free-From” & Allergen-Free Claim Substantiation (e.g., gluten-free, peanut-free) (AFALAHAD)
- akta.pro secondary industries
- Labeling, Nutrition Facts & Allergen Verification Services (AFALAAAH), Food Testing Laboratories (Microbiological, Chemical, Allergen) (AFALAAAA), Method Development & Validation (ICH/USP) (HLAGADAB)
Keywords
Where Aalto Helsinki is headquartered
LocationHeadquarters
- HQ city
- Helsinki
- HQ country
- Finland
- HQ region
- Europe
Offices2 records
Markets served
Aalto Helsinki business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Revenue model
- Competition funding and sponsorships: Student team funded through university support, private sponsors, and competition grants. No commercial revenue generation.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Aalto Helsinki product offering
Product offeringCore offering
Aalto Helsinki is a student-driven synthetic biology research team that produces annual proof-of-concept biotechnology projects for the international iGEM competition. The team combines biology, biotechnology, bioinformatics, chemistry, mathematics, programming, design, and engineering expertise to develop synthetic biology solutions addressing healthcare, environmental, and sustainability challenges. Their current 2026 offering is a fusion protein-based histamine test-strip biosensor for home-use detection of histamine in food by people with histamine intolerance.
Product overview
Aalto Helsinki is a student-driven research team participating in the iGEM (International Genetically Engineered Machine) synthetic biology competition. The team comprises students from Aalto University and University of Helsinki working on annual biotechnology research projects. Their 2026 project focuses on developing a fusion protein-based histamine test-strip biosensor for home-use by people with histamine intolerance. Historical projects have included PET upcycling (2023), QBlock for chronic wound treatment (2022), dermcidin-based acne treatment (2017), natural dye production with spider silk proteins (2018), cyanotoxin detection from blue-green algae (2016), propane production (2015), and remote-controlled bacterial gene expression (2014). These are academic research projects, not commercial products.
Differentiator
Problem solved
Functional benefit
Products and services
- Biosensor for Histamine Detection (iGEM 2026 project) A fusion protein-based home-use histamine test-strip biosensor targeting people with histamine intolerance (approximately 1% of the global population). The strip combines a diamine oxidase (DAO) domain for histamine degradation, a color-changing enzyme that responds to hydrogen peroxide, and a cellulose-binding protein to anchor the complex onto the test strip. Designed for everyday consumer use to detect histamine in foods such as cheese, wine, fermented foods, spinach, and seafood.
Quantifiable outcome
- Gold Medal achievement at 2022 Grand Jamboree
- +1 more outcomes
Companies that use Aalto Helsinki
Customer profileSegments5 records
Ideal customer profiles2 records
Aalto Helsinki technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Aalto Helsinki partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered major, minor and core.
- Codex DNAmajorCollaboration to test BioXp DNA, mRNA, and protein synthesizing machine. Received opportunity to synthesize DARPin DNA fragments for the 2022 project.
- Immuno Diagnostics OymajorFinnish distributor for Codex DNA products, facilitated BioXp machine access and provided technical support.
- TU DresdenmajorMain research collaborator on dry-lab side for computational modeling of DARPin passage through biofilm matrix. Both teams focus on chronic wound healing.
- Aboa (Turku) iGEM TeamminorOnly other Finnish iGEM team collaboration for workshops at Heureka, Science Basement presentations, and bioethics discussions.
- HiLife (Helsinki Institute of Life Science)coreHelsinki Institute of Life Science provides institutional support and laboratory facilities. Logo displayed on partner section of website.
- University of Helsinki DepartmentscoreFaculty of Science, Department of Food Sciences, and other departments provide academic support and resources.
- Thermo Fisher ScientificmajorProvides laboratory equipment and reagents sponsorship. Logo displayed on partner section.
- HeurekamajorFinnish Science Center collaborator for educational workshops and outreach programs, particularly for children.
- VTT Technical Research Centre of FinlandcoreResearch institution providing laboratory space and scientific expertise.
- Aalto UniversitycoreHome university providing primary institutional support, laboratory space, and mentorship from professors and staff.
- University of HelsinkicorePartner university providing academic support and research facilities.
- AaltoESminorAalto University startup society providing entrepreneurial support and connections.
- IDT (Integrated DNA Technologies)majorDNA synthesis and reagents provider, long-term sponsor.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Aalto Helsinki competitors and assessment
Company assessmentBroad incumbents
- Codexis: Industrial synthetic biology company developing engineered enzymes for pharmaceutical manufacturing and sustainable chemistry. Comparable as a commercial-scale application of protein engineering and enzyme design concepts that iGEM teams like Aalto-Helsinki explore academically through DARPin and fusion protein work.
- Ginkgo Bioworks: Founded by former iGEM participants, Ginkgo is the largest publicly-traded synthetic biology platform company. Comparable as the commercial maturation of iGEM-style synthetic biology into industrial-scale cell engineering, though operating at vastly larger scale with full equity and revenue structure.
- Amyris: Synthetic biology company producing sustainable ingredients via engineered microbes. Comparable as a commercial-stage example of microbial strain engineering for sustainable consumer products, paralleling Aalto-Helsinki's natural dye production and PET upcycling projects at industrial scale.
- Twist Bioscience: Commercial DNA synthesis platform serving synthetic biology researchers globally. Comparable as commercial infrastructure for synthetic biology, with which Aalto-Helsinki's projects (DNA assembly, BioBrick parts, biosensor engineering) directly interact and depend upon.
Others
- Thermo Fisher Scientific: Major life sciences tools provider and equipment sponsor for Aalto-Helsinki. Comparable as the dominant infrastructure provider whose reagents, instruments, and laboratory equipment underpin synthetic biology research across academia and industry.
- Integrated DNA Technologies (IDT): DNA synthesis and reagents provider that is a long-term sponsor of Aalto-Helsinki. Comparable as a key enabling technology partner whose oligonucleotide products and DNA synthesis services directly underpin the team's synthetic biology research workflows.
- Codex DNA: Synthetic biology tools company providing the BioXp DNA/mRNA/protein synthesis machine used by Aalto-Helsinki for their 2022 DARPin project. Directly comparable as a technology partner enabling rapid DNA-to-protein workflows central to synthetic biology prototyping.
- VTT Technical Research Centre of Finland: Finnish research institution providing laboratory space, equipment, and scientific expertise to Aalto-Helsinki. Comparable as a domestic applied research partner bridging academic synthetic biology to industrial applications within the Finnish bioeconomy.
Direct peers
- Aboa (Turku) iGEM Team: The only other Finnish iGEM team, with whom Aalto-Helsinki collaborates on workshops at Heureka science center, joint bioethics discussions, and Science Basement presentations. Both are student-driven synthetic biology competition teams operating in the same Finnish geographic market with similar academic structures.
- MIT iGEM Team: Historically the most successful iGEM team globally, originating the competition itself and producing multiple gold medal winners and category winners. Directly comparable as a leading student-driven synthetic biology team with elite institutional backing, multidisciplinary structure, and consistent gold medal track record.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Aalto Helsinki social profiles
Digital presenceAalto Helsinki financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aalto Helsinki leadership team
Management profileNumber of profiles
Profiles3 records
Aalto Helsinki funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aalto Helsinki M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aalto Helsinki
What does Aalto Helsinki do?
Aalto Helsinki is a student-driven synthetic biology research team that produces annual proof-of-concept biotechnology projects for the international iGEM competition. The team combines biology, biotechnology, bioinformatics, chemistry, mathematics, programming, design, and engineering expertise to develop synthetic biology solutions addressing healthcare, environmental, and sustainability challenges. Their current 2026 offering is a fusion protein-based histamine test-strip biosensor for home-use detection of histamine in food by people with histamine intolerance.
Is Aalto Helsinki a public or private company?
Aalto Helsinki is a private company. It is classified as unknown and is currently operating.
When was Aalto Helsinki founded?
Aalto Helsinki was founded in 2014. It employs 1 to 10 people.
Where is Aalto Helsinki based?
Aalto Helsinki is headquartered in Helsinki, Finland, in the Europe region.
How does Aalto Helsinki make money?
One revenue line is on record: competition funding and sponsorships.
Who are Aalto Helsinki's main competitors?
Broad incumbents on record are Codexis, Ginkgo Bioworks, Amyris and Twist Bioscience. Others are Thermo Fisher Scientific, Integrated DNA Technologies (IDT), Codex DNA and VTT Technical Research Centre of Finland. Direct peers are Aboa (Turku) iGEM Team and MIT iGEM Team.
Does Aalto Helsinki have an API?
No public API is recorded for Aalto Helsinki.
What industry is Aalto Helsinki in?
Aalto Helsinki's product category is Synthetic Biology Research. Its primary akta.pro industry code is AFALAHAD, “Free-From” & Allergen-Free Claim Substantiation (e.g., gluten-free, peanut-free), with a secondary code of AFALAAAH, Labeling, Nutrition Facts & Allergen Verification Services. Its NAICS code is 334516 and its SIC code is 8731.